Float Raises $10 Million Series A to Treat Chronic Illness and Alleviate

Thursday, Mar 28, 2024

Illustration of a patient receiving IV medication at home

Growing Strain on our Healthcare System

At a time of hospital overcrowding, rising nursing burnout, and surging chronic illnesses, Float benefits patients, nurses, prescribers, pharmacies, payers, and health systems alike.

Float, the marketplace moving all the care that doesn’t need a hospital to the home, today announced $10 million in Series A funding led by Canvas Ventures, whose General Partner Mike Ghaffary has joined Float’s board, with participation from Wave Capital, Y Combinator, Burst Capital, and Also Capital. Several tech industry founders and leaders joined as angels, including Max Mullen, Co-founder of Instacart, Andrew Bartynski, Vice President of Strategy and Operations at ASRI, Brian Pokorny, former General Partner of SV Angel, Jed Nachman, COO of Yelp, and Brian Osborn, former VP of Marketing at Yelp.

With $15 million in total funding, Float has the capital, talent, and technology to continue tackling a root cause of healthcare’s most pressing issues: chronic illness. 133 million Americans suffer from a chronic illness, and that number continues to rise at an alarming rate. Many chronic conditions, such as multiple sclerosis and other autoimmune diseases, require specialty medicines that can only be given through a needle by an experienced nurse. To find a nurse who can administer medicines by injection or through an IV, most people head to their local hospitals, which are not built for routine care. This has become a major contributor to hospital overcrowding, increased administrative burdens, and staffing shortages – all of which cost healthcare systems hundreds of billions of dollars every year.

Float is a rare win for everyone — from patients, caregivers, nurses, prescribers, pharmacies, payers, health systems, and ultimately anyone in the United States. Instead of forcing patients with chronic illnesses to go to overcrowded hospitals full of sick people for routine care, Float brings the best of the hospital to their homes: highly skilled nurses who can provide personalized care.

Founded in 2021 by former ER nurse Ryan Johnson, CEO and Christy Johnson, COO, Float has built a network of hundreds of nurses across California and Arizona. Ryan’s experience in nursing along with Christy’s background in startups and operations allowed them to recognize the massive need to scale their service to expand access to specialty infusions. Float’s customers are some of the biggest names in specialty medicine, such as Optum, CVS, Option Care, Alliance RX (Walgreen’s), Kroger, Kabafusion, Soleo Health, NuFactor, Care Fusion, CA Specialty Pharmacy, and more.

“After years in the emergency room treating patients with chronic conditions, and from treating my dad who suffers from one, I realized that moving specialty medicine into the home would be a sea change for everyone, ” said Johnson. “Expanding access to this type of care would have a huge impact on patient outcomes, not to mention the burnout of my nurse friends exhausted by long shifts and juggling priorities. Float has proven successful in doing exactly that.”

Proven impact

About Float

Float is the marketplace moving all the care that doesn’t need a hospital to the home. The company provides a myriad of services from scheduling, to vetting, to ensuring timely charting and invoicing for insurance that enables specialty treatment for patients easily at their home. Founded in 2021, Float has built a network of thousands of highly skilled nurses across California and Arizona to deliver high-quality care to patients suffering from chronic illness. Its customers include some of the largest names in specialty medicine including Optum, CVS, Option Care, Alliance RX (Walgreens), Kroger, Kabafusion, Soleo Health, NuFactor, Care Fusion, and CA Specialty Pharmacy, and more.